TY - JOUR
T1 - COVID-19 vaccination in our transplant recipients
T2 - The time is now
AU - Aslam, Saima
AU - Goldstein, Daniel R.
AU - Vos, Robin
AU - Gelman, Andrew E.
AU - Kittleson, Michelle M.
AU - Wolfe, Cameron
AU - Danziger-Isakov, Lara
N1 - Publisher Copyright:
© 2021 International Society for Heart and Lung Transplantation
PY - 2021/3
Y1 - 2021/3
N2 - We are entering 2021 with an expanding and effective COVID-19 vaccine armamentarium. Recent interim results from COVID-19 vaccine trials, including more than 80,000 participants worldwide, demonstrate remarkable efficacy and low rate of serious adverse events. Based on experience with other vaccines in transplant recipients and knowing the risk of severe COVID-19 in this population, we believe that COVID-19 vaccines provide potential benefit with minimal risk. We strongly support and encourage COVID-19 vaccination of our transplant recipients.
AB - We are entering 2021 with an expanding and effective COVID-19 vaccine armamentarium. Recent interim results from COVID-19 vaccine trials, including more than 80,000 participants worldwide, demonstrate remarkable efficacy and low rate of serious adverse events. Based on experience with other vaccines in transplant recipients and knowing the risk of severe COVID-19 in this population, we believe that COVID-19 vaccines provide potential benefit with minimal risk. We strongly support and encourage COVID-19 vaccination of our transplant recipients.
KW - COVID-19
KW - SARS-CoV-2
KW - pandemic
KW - transplant
KW - vaccination
KW - vaccine
UR - http://www.scopus.com/inward/record.url?scp=85099678476&partnerID=8YFLogxK
U2 - 10.1016/j.healun.2020.12.009
DO - 10.1016/j.healun.2020.12.009
M3 - Editorial
C2 - 33487534
AN - SCOPUS:85099678476
SN - 1053-2498
VL - 40
SP - 169
EP - 171
JO - Journal of Heart and Lung Transplantation
JF - Journal of Heart and Lung Transplantation
IS - 3
ER -